Perclose Techstar XL 6 French puncture closure device shipments resume after recall.
This article was originally published in The Gray Sheet
Executive Summary
PERCLOSE TECHSTAR XL 6F SHIPMENTS BACK ON TRACK DEC. 5 following a recall of the suture-based closure systems that required a change in manufacturing procedures by the firm. Production recommenced late last month after the replacement of defective molding equipment used to make the device, which is used to seal femoral artery punctures following an angiogram.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.